Insiders · Profile

Marvin Donald

Executive VP, CFO & COO at Chemomab Therapeutics. Filing since 14 Mar 2022. CIK 0001891264

Company
Date
Role
Action
Shares
Amount
Of holding
16 Mar 2022
Executive VP, CFO & COO
Bought
500
$1.64K
33.3%
14 Mar 2022
Executive VP, CFO & COO
Bought
1,250
$5.05K
500%
2 decisions on file.